A duo of former executives from beleaguered drug maker Valeant and its defunct mail order pharmacy Philidor have been found guilty of a multimillion dollar fraud – and the f
Valeant has sold its controversial female libido drug to former shareholders in Sprout, the company that first developed it before a $1 billion buyout two years ago.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh